Home » Maaz Rafique

Maaz Rafique

Senior Analyst

Maaz Rafique was a Senior Analyst at CBPartners.

Connect with Maaz Rafique



Published Articles

KYMRIAH and TRELEGY Become the First Drugs to Undergo Japan’s New CEA System

What can be learned from the first use of Japan's new Cost-Effectiveness Assessment (CEA) system? Read CBPartners' infographic here.

Applying Technology in Pharma (ATP): Assessment of Investment Trends in Digital Health

VC investment in digital healthcare has been growing rapidly (+42% vs. 2017) as the potential of new technology to solve complex issues, ranging from providing healthcare services to managing chronic conditions, evolves. CBPartners takes a look at investment trends in digital health.